Press release
United States Catheter-Related Bloodstream Infection Drugs Market 2025 | Exclusive Report by DatamIntelligence
Catheter-Related Bloodstream Infection Drugs Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/catheter-related-bloodstream-infection-drugs-market?sp
United States: Recent Industry Developments
✅ In September 2025, Pfizer launched a novel antibiotic therapy targeting catheter-related bloodstream infections with improved efficacy against multi-drug resistant pathogens. The therapy aims to reduce infection rates in hospitalized patients.
✅ In August 2025, Merck expanded clinical trials for an advanced antimicrobial agent for CRBSI, evaluating safety, long-term outcomes, and efficacy in high-risk populations. The initiative strengthens the U.S. infectious disease pipeline.
✅ In July 2025, Cubist Pharmaceuticals introduced next-generation catheter coatings with integrated antimicrobial drugs to prevent bloodstream infections, supporting safer intravenous therapy.
✅ In June 2025, Johnson & Johnson invested in R&D for innovative therapies and coatings for CRBSI prevention, combining precision-targeted antibiotics with biomaterial technology to enhance patient safety.
Japan: Recent Industry Developments
✅ In September 2025, Takeda Pharmaceutical launched targeted therapies for catheter-related bloodstream infections with improved safety and efficacy for hospitalized patients, focusing on multi-drug resistant pathogens.
✅ In August 2025, Astellas Pharma expanded clinical trials for CRBSI antimicrobial agents, emphasizing early intervention and personalized treatment strategies.
✅ In July 2025, Chugai Pharmaceutical developed advanced catheter coatings with integrated antimicrobial drugs to prevent bloodstream infections and improve patient outcomes.
✅ In June 2025, Otsuka Pharmaceutical invested in R&D for next-generation CRBSI therapies combining targeted antimicrobial action and innovative catheter technologies, promoting safer clinical practices.
Catheter-Related Bloodstream Infection Drugs Market: Drivers
The catheter-related bloodstream infection (CRBSI) drugs market is witnessing steady growth, driven by the increasing prevalence of hospital-acquired infections, rising use of central venous catheters, and growing emphasis on infection prevention in healthcare settings. CRBSIs, caused by bacterial or fungal contamination of indwelling catheters, pose serious complications including sepsis, prolonged hospitalization, and higher mortality rates, creating demand for effective antimicrobial and therapeutic interventions. Advances in antibiotic, antifungal, and novel anti-infective formulations are improving treatment efficacy, targeting resistant strains, and reducing recurrence rates. Rising awareness among healthcare professionals and implementation of stringent infection control protocols are supporting adoption of CRBSI management therapies. Expansion of hospital infrastructure, intensive care units, and catheter-based medical procedures is further driving market growth.
Key pharmaceutical companies such as Pfizer, Merck, Novartis, and GlaxoSmithKline are developing and commercializing targeted therapies for the prevention and treatment of CRBSIs, including antibiotics, antiseptic lock solutions, and combination therapies. Increasing research in antimicrobial coatings, catheter-compatible drug delivery systems, and novel biologics is expanding therapeutic options. Regulatory support and clinical guidelines promoting early intervention and prophylactic treatment are encouraging widespread adoption. Collaborations between healthcare providers, research institutions, and pharmaceutical companies are accelerating innovation and patient access. With growing hospital-acquired infection concerns, technological advancements, and rising healthcare infrastructure, the CRBSI drugs market is poised for sustained global growth.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/catheter-related-bloodstream-infection-drugs-market?sp
Catheter-Related Bloodstream Infection Drugs Market: Major Players
Hikma Pharmaceuticals PLC, Zhejiang Novus Pharmaceuticals Co., Ltd., Pfizer, Inc., SteriMax, Baxter, Fresenius Kabi USA, Merck & Co., Inc., Xellia Pharmaceuticals, AdvaCare Pharma, and Avet Pharmaceuticals Inc. among others.
Segment Covered in the Catheter-Related Bloodstream Infection Drugs Market:
➥ By Causative Organisms: Bacterial Infections, Fungal Infection, Viral and Parasitic Infections
➥ By Drug Class: Antibiotics, Antifungals, Antivirals, Others
➥ By Route of Administration: Oral, Injectable
➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Research Process:
Both primary and secondary data sources have been used in the Catheter-Related Bloodstream Infection Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the Catheter-Related Bloodstream Infection Drugs Market Research Industry:
➠ Who leads the Catheter-Related Bloodstream Infection Drugs industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Catheter-Related Bloodstream Infection Drugs market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Catheter-Related Bloodstream Infection Drugs market growth?
➠ What are the dominant sales and distribution strategies in the Catheter-Related Bloodstream Infection Drugs industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=catheter-related-bloodstream-infection-drugs-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Catheter-Related Bloodstream Infection Drugs Market 2025 | Exclusive Report by DatamIntelligence here
News-ID: 4223591 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market …
Market Size and Growth
The Global Immunohistochemistry Market size was valued at US$ 2,302.79 million in 2022 and is estimated to reach US$4,240.65 million by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/immunohistochemistry-market?sb
Key Development:
United States: Recent Industry Developments
✅ In February 2026, the U.S. Food and Drug Administration approved PD‐L1 IHC 22C3 pharmDx…
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads …
Market Overview
Market Size (2024): USD 328.19 billion
Expected Market Size (2032): USD 586.63 billion
CAGR (2025-2032): 7.53%
The global critical minerals market is experiencing unprecedented growth, driven primarily by the accelerating transition to clean energy technologies. Key energy transition minerals including lithium, cobalt, and nickel have seen rapid demand growth: lithium demand has tripled, cobalt demand has risen by 70%, and nickel demand has increased by 40% between 2017 and 2022. Clean energy…
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America L …
Market Overview
Market Size (2023): USD 7.26 billion
Expected Market Size (2033): USD 12.31 billion
CAGR (2025-2033): 5.3%
Drug abuse testing is a critical process for detecting prescription and illicit substances in an individual's system, ensuring safety, regulatory compliance, and medical evaluation. It is widely used across workplace screening, forensic investigations, sports anti-doping programs, and clinical diagnostics.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/drug-of-abuse-testing-market?Juli
Advancements in rapid detection…
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, …
Market Size and Growth
Aesthetic Lasers and Energy Devices Market is estimated to reach at a CAGR of 6.40% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/aesthetic-lasers-and-energy-devices-market?sb
Key Development:
United States: Recent Industry Developments
✅ In November 2025, Venus Concept Inc. secured FDA 510(k) clearance for its Venus NOVATM platform, a next‐generation multi‐application device combining radiofrequency, EMS, and electromagnetic technologies for non‐invasive…
More Releases for Infection
Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Infection Prevention Market?
In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market…
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market?
The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization.
The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven…
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The yeast infection…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing…
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
